Results 191 to 200 of about 15,339 (215)
Some of the next articles are maybe not open access.
[Uremic toxins: the case of protein-bound compounds].
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2010Uremic retention solutes, if biologically or biochemically active, are called ''uremic toxins''. The retention of these solutes has a negative impact on many functions of the organism, particularly the cardiovascular system. The classification which is applied today is based on the kinetic behavior of the uremic retention solutes during dialysis: 1 ...
Carlo, Basile +3 more
openaire +1 more source
New therapeutic perspectives on protein-bound uremic toxins in chronic kidney disease
Expert Opinion on Therapeutic Targets, 2013The uremic syndrome is a complex mosaic of clinical alterations that may be attributable to one or more of these different solutes. Uremic symptoms in patients with chronic kidney disease are primarily a consequence of inadequate removal and subsequent accumulation of organic products normally metabolized or excreted by the kidney.
openaire +2 more sources
Kinetics of the protein-bound, lipophilic, uremic toxin p-cresol in healthy rats
Life Sciences, 2001P-Cresol, a partially lipophilic and protein-bound compound is related to several biochemical alterations in uremia. Because p-cresol kinetics have never been studied, we investigated its kinetic behavior in rats. Results were compared with those obtained with creatinine, a water soluble, non-protein-bound uremic retention solute, which is currently ...
Lesaffer, Gerrit +5 more
openaire +3 more sources
Biochimie, 2017
Little is known about potential differences in binding characteristics of protein-bound uremic toxins (PBUTs) in patients with chronic kidney disease (CKD) versus healthy controls. The question arises whether eventual differences are attributed to (i) the elevated levels of competing uremic toxins, and/or (ii) post-translational modifications of ...
Olivier Deltombe +6 more
openaire +2 more sources
Little is known about potential differences in binding characteristics of protein-bound uremic toxins (PBUTs) in patients with chronic kidney disease (CKD) versus healthy controls. The question arises whether eventual differences are attributed to (i) the elevated levels of competing uremic toxins, and/or (ii) post-translational modifications of ...
Olivier Deltombe +6 more
openaire +2 more sources
New Optical Method for Estimation of Protein Bound Uremic Toxins Elimination
2013The aim of this study was to investigate the possibility to determine the amount of removed Indoxyl Sulphate (IS) during dialysis session. An optical method using fluorescence spectra was used.
J. Holmar +4 more
openaire +1 more source
Blood Purification
Introduction: The optimal duration of hemoadsorption durations combined with hemodialysis (HAHD) for maintenance hemodialysis (MHD) patients remains unclear.
Yang Lu +8 more
semanticscholar +1 more source
Introduction: The optimal duration of hemoadsorption durations combined with hemodialysis (HAHD) for maintenance hemodialysis (MHD) patients remains unclear.
Yang Lu +8 more
semanticscholar +1 more source
Journal of Clinical Medicine
Background/Objectives: Protein-bound uremic toxins (PBUTs), particularly p-cresyl sulfate (PCS) and indoxyl sulfate (IS), are associated with cardiovascular toxicity and increased mortality.
Tjaša Herič +6 more
semanticscholar +1 more source
Background/Objectives: Protein-bound uremic toxins (PBUTs), particularly p-cresyl sulfate (PCS) and indoxyl sulfate (IS), are associated with cardiovascular toxicity and increased mortality.
Tjaša Herič +6 more
semanticscholar +1 more source
Animal Models for Studying Protein-Bound Uremic Toxin Removal
Journal of the American Society of Nephrology, 2023Sabbir Ahmed +7 more
openaire +1 more source
Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence
Toxins, 2022Jia-Huang Chen, Chih-Kang Chiang
exaly

